Inclusion body myositis long after dermatomyositis : A report of two cases
Dermatomyositis, polymyositis, and inclusion body myositis are rare illnesses which appear to be distinct in clinical and pathologic features, pathogenesis, natural history, and response to therapy. We report two patients who first developed dermatomyositis, and then, after a disease-free interval o...
Gespeichert in:
Veröffentlicht in: | Clinical and experimental rheumatology 1999-03, Vol.17 (2), p.235-239 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 239 |
---|---|
container_issue | 2 |
container_start_page | 235 |
container_title | Clinical and experimental rheumatology |
container_volume | 17 |
creator | MCCOY, A. L BUBB, M. R PLOTZ, P. H DAVIS, J. C |
description | Dermatomyositis, polymyositis, and inclusion body myositis are rare illnesses which appear to be distinct in clinical and pathologic features, pathogenesis, natural history, and response to therapy. We report two patients who first developed dermatomyositis, and then, after a disease-free interval of many years, developed inclusion body myositis. This may have useful therapeutic implications for patients with dermatomyositis whose illness bocomes refractory to treatment. |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_69789232</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69789232</sourcerecordid><originalsourceid>FETCH-LOGICAL-p236t-d200906316850bff16e0c4c74234710bffd82ebda23760a7e4d8636879ad1dd83</originalsourceid><addsrcrecordid>eNpFz81KxDAUBeAgijOOvoJkIe4KaZLmx90w6Dgy4EZhdiVNUqm0Tc1Nkb69I1ZdXTjn48A9Qcu80CwjWh1O0ZIwTTNViMMCXQC8E0JFIeQ5WuSEcUoKtkRPu962IzShx1VwE-6mAE1qALehf8OmTj5i52NnUvir7vAaRz-EmHCocfoM2BrwcInOatOCv5rvCr0-3L9sHrP983a3We-zgTKRMkcJ0USwXKiCVHWdC08st5JTxmX-nThFfeUMZVIQIz13SjChpDYud06xFbr92R1i-Bg9pLJrwPq2Nb0PI5RCS6Upo0d4PcOx6rwrh9h0Jk7l7_dHcDMDA9a0dTS9beDfSSk51-wLA11jkw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69789232</pqid></control><display><type>article</type><title>Inclusion body myositis long after dermatomyositis : A report of two cases</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>MCCOY, A. L ; BUBB, M. R ; PLOTZ, P. H ; DAVIS, J. C</creator><creatorcontrib>MCCOY, A. L ; BUBB, M. R ; PLOTZ, P. H ; DAVIS, J. C</creatorcontrib><description>Dermatomyositis, polymyositis, and inclusion body myositis are rare illnesses which appear to be distinct in clinical and pathologic features, pathogenesis, natural history, and response to therapy. We report two patients who first developed dermatomyositis, and then, after a disease-free interval of many years, developed inclusion body myositis. This may have useful therapeutic implications for patients with dermatomyositis whose illness bocomes refractory to treatment.</description><identifier>ISSN: 0392-856X</identifier><identifier>EISSN: 1593-098X</identifier><identifier>PMID: 10342053</identifier><language>eng</language><publisher>Pisa: Clinical and Experimental Rheumatology</publisher><subject>Adult ; Azathioprine - therapeutic use ; Biological and medical sciences ; Creatine Kinase - blood ; Dermatomyositis - complications ; Dermatomyositis - drug therapy ; Dermatomyositis - enzymology ; Dermatomyositis - pathology ; Humans ; Male ; Medical sciences ; Middle Aged ; Muscle, Skeletal - pathology ; Myositis, Inclusion Body - complications ; Myositis, Inclusion Body - drug therapy ; Myositis, Inclusion Body - enzymology ; Myositis, Inclusion Body - pathology ; Prednisolone - therapeutic use ; Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis</subject><ispartof>Clinical and experimental rheumatology, 1999-03, Vol.17 (2), p.235-239</ispartof><rights>1999 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1777449$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10342053$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>MCCOY, A. L</creatorcontrib><creatorcontrib>BUBB, M. R</creatorcontrib><creatorcontrib>PLOTZ, P. H</creatorcontrib><creatorcontrib>DAVIS, J. C</creatorcontrib><title>Inclusion body myositis long after dermatomyositis : A report of two cases</title><title>Clinical and experimental rheumatology</title><addtitle>Clin Exp Rheumatol</addtitle><description>Dermatomyositis, polymyositis, and inclusion body myositis are rare illnesses which appear to be distinct in clinical and pathologic features, pathogenesis, natural history, and response to therapy. We report two patients who first developed dermatomyositis, and then, after a disease-free interval of many years, developed inclusion body myositis. This may have useful therapeutic implications for patients with dermatomyositis whose illness bocomes refractory to treatment.</description><subject>Adult</subject><subject>Azathioprine - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Creatine Kinase - blood</subject><subject>Dermatomyositis - complications</subject><subject>Dermatomyositis - drug therapy</subject><subject>Dermatomyositis - enzymology</subject><subject>Dermatomyositis - pathology</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Muscle, Skeletal - pathology</subject><subject>Myositis, Inclusion Body - complications</subject><subject>Myositis, Inclusion Body - drug therapy</subject><subject>Myositis, Inclusion Body - enzymology</subject><subject>Myositis, Inclusion Body - pathology</subject><subject>Prednisolone - therapeutic use</subject><subject>Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis</subject><issn>0392-856X</issn><issn>1593-098X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFz81KxDAUBeAgijOOvoJkIe4KaZLmx90w6Dgy4EZhdiVNUqm0Tc1Nkb69I1ZdXTjn48A9Qcu80CwjWh1O0ZIwTTNViMMCXQC8E0JFIeQ5WuSEcUoKtkRPu962IzShx1VwE-6mAE1qALehf8OmTj5i52NnUvir7vAaRz-EmHCocfoM2BrwcInOatOCv5rvCr0-3L9sHrP983a3We-zgTKRMkcJ0USwXKiCVHWdC08st5JTxmX-nThFfeUMZVIQIz13SjChpDYud06xFbr92R1i-Bg9pLJrwPq2Nb0PI5RCS6Upo0d4PcOx6rwrh9h0Jk7l7_dHcDMDA9a0dTS9beDfSSk51-wLA11jkw</recordid><startdate>19990301</startdate><enddate>19990301</enddate><creator>MCCOY, A. L</creator><creator>BUBB, M. R</creator><creator>PLOTZ, P. H</creator><creator>DAVIS, J. C</creator><general>Clinical and Experimental Rheumatology</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>19990301</creationdate><title>Inclusion body myositis long after dermatomyositis : A report of two cases</title><author>MCCOY, A. L ; BUBB, M. R ; PLOTZ, P. H ; DAVIS, J. C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p236t-d200906316850bff16e0c4c74234710bffd82ebda23760a7e4d8636879ad1dd83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Adult</topic><topic>Azathioprine - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Creatine Kinase - blood</topic><topic>Dermatomyositis - complications</topic><topic>Dermatomyositis - drug therapy</topic><topic>Dermatomyositis - enzymology</topic><topic>Dermatomyositis - pathology</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Muscle, Skeletal - pathology</topic><topic>Myositis, Inclusion Body - complications</topic><topic>Myositis, Inclusion Body - drug therapy</topic><topic>Myositis, Inclusion Body - enzymology</topic><topic>Myositis, Inclusion Body - pathology</topic><topic>Prednisolone - therapeutic use</topic><topic>Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>MCCOY, A. L</creatorcontrib><creatorcontrib>BUBB, M. R</creatorcontrib><creatorcontrib>PLOTZ, P. H</creatorcontrib><creatorcontrib>DAVIS, J. C</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical and experimental rheumatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>MCCOY, A. L</au><au>BUBB, M. R</au><au>PLOTZ, P. H</au><au>DAVIS, J. C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Inclusion body myositis long after dermatomyositis : A report of two cases</atitle><jtitle>Clinical and experimental rheumatology</jtitle><addtitle>Clin Exp Rheumatol</addtitle><date>1999-03-01</date><risdate>1999</risdate><volume>17</volume><issue>2</issue><spage>235</spage><epage>239</epage><pages>235-239</pages><issn>0392-856X</issn><eissn>1593-098X</eissn><abstract>Dermatomyositis, polymyositis, and inclusion body myositis are rare illnesses which appear to be distinct in clinical and pathologic features, pathogenesis, natural history, and response to therapy. We report two patients who first developed dermatomyositis, and then, after a disease-free interval of many years, developed inclusion body myositis. This may have useful therapeutic implications for patients with dermatomyositis whose illness bocomes refractory to treatment.</abstract><cop>Pisa</cop><pub>Clinical and Experimental Rheumatology</pub><pmid>10342053</pmid><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0392-856X |
ispartof | Clinical and experimental rheumatology, 1999-03, Vol.17 (2), p.235-239 |
issn | 0392-856X 1593-098X |
language | eng |
recordid | cdi_proquest_miscellaneous_69789232 |
source | MEDLINE; Alma/SFX Local Collection |
subjects | Adult Azathioprine - therapeutic use Biological and medical sciences Creatine Kinase - blood Dermatomyositis - complications Dermatomyositis - drug therapy Dermatomyositis - enzymology Dermatomyositis - pathology Humans Male Medical sciences Middle Aged Muscle, Skeletal - pathology Myositis, Inclusion Body - complications Myositis, Inclusion Body - drug therapy Myositis, Inclusion Body - enzymology Myositis, Inclusion Body - pathology Prednisolone - therapeutic use Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis |
title | Inclusion body myositis long after dermatomyositis : A report of two cases |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T02%3A04%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Inclusion%20body%20myositis%20long%20after%20dermatomyositis%20:%20A%20report%20of%20two%20cases&rft.jtitle=Clinical%20and%20experimental%20rheumatology&rft.au=MCCOY,%20A.%20L&rft.date=1999-03-01&rft.volume=17&rft.issue=2&rft.spage=235&rft.epage=239&rft.pages=235-239&rft.issn=0392-856X&rft.eissn=1593-098X&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E69789232%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69789232&rft_id=info:pmid/10342053&rfr_iscdi=true |